<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03176641</url>
  </required_header>
  <id_info>
    <org_study_id>RA-16027-RD-105063</org_study_id>
    <nct_id>NCT03176641</nct_id>
  </id_info>
  <brief_title>Platelet-rich Plasma for Meniscus Repair</brief_title>
  <official_title>Efficacy of Platelet-rich Plasma on Meniscus Repair- a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pei-Yuan Lee, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aeon Biotechnology Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Show Chwan Memorial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the effect of platelet-rich plasma (PRP) on meniscus injury by
      comparing the imaging and clinical outcomes between patients receiving PRP with meniscus
      repair surgery and those receiving meniscus repair surgery only.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Damage to meniscal tissue is challenging for orthopedic surgeons because of the absence of
      healing at the avascular zone. Additionally, the accelerated degeneration of articular
      cartilage and increased rate of knee osteoarthritis that can occur following a meniscal
      injury. Platelet-rich plasma (PRP) is a fraction of plasma that contains platelets and
      multiple growth factors concentrated at high level. Because activated platelets have the
      potential to release growth factors, PRP has been clinically used to accelerate wound healing
      and tissue regeneration in orthopedic and oral surgery. Several in vivo and in vitro studies
      have reported favorable outcomes of PRP on meniscal repair; however, the clinical results
      varied between studies.This clinical trial will investigate the effect of PRP on on meniscus
      injury. Eligible patients will be randomly assigned to receive PRP with meniscus repair
      surgery or to receive meniscus repair surgery only. The postoperative imaging and clinical
      outcomes will be compared and analyzed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 24, 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>3-month postoperative knee function evaluated by IKDC</measure>
    <time_frame>3-month postoperative</time_frame>
    <description>Knee function is evaluated using International Knee Documentation Committee (IKDC) score.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>6-month postoperative knee function evaluated by IKDC</measure>
    <time_frame>6-month postoperative</time_frame>
    <description>Knee function is evaluated using International Knee Documentation Committee (IKDC) score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12-month postoperative knee function evaluated by IKDC</measure>
    <time_frame>12-month postoperative</time_frame>
    <description>Knee function is evaluated using International Knee Documentation Committee (IKDC) score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3-month postoperative knee pain evaluated by VAS</measure>
    <time_frame>3-month postoperative</time_frame>
    <description>Pain level is evaluated using visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-month postoperative knee pain evaluated by VAS</measure>
    <time_frame>6-month postoperative</time_frame>
    <description>Pain level is evaluated using visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12-month postoperative knee pain evaluated by VAS</measure>
    <time_frame>12-month postoperative</time_frame>
    <description>Pain level is evaluated using visual analogue scale (VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with healed meniscus 6-month postoperative</measure>
    <time_frame>6-month postoperative</time_frame>
    <description>Healing of meniscus is evaluated by MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients with healed meniscus 12-month postoperative</measure>
    <time_frame>12-month postoperative</time_frame>
    <description>Healing of meniscus is evaluated by MRI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Platelet-Rich Plasma</condition>
  <condition>Knee Injuries</condition>
  <condition>Meniscus Disorder</condition>
  <arm_group>
    <arm_group_label>PRP group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30 patients will receive autologous platelet-rich plasma gel during meniscus repair surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>30 patients will receive meniscus repair surgery only.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>platelet-rich plasma</intervention_name>
    <description>Autologous platelet-rich plasma gel applied during meniscus repair surgery</description>
    <arm_group_label>PRP group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control</intervention_name>
    <description>Meniscus repair surgery only</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 20 and 60 years

          -  With diagnosis of meniscus injury

          -  With indications of meniscus repair surgery

        Exclusion Criteria:

          -  Multiple ligaments injury

          -  with prior history of knee surgery

          -  Cancer patients

          -  Pregnancy

          -  Patients who will not cooperate with one-year followup
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pei-Yuan Lee, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Show Chwan Memorial Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chien-Sheng Lo, MD</last_name>
    <phone>+886-975611289</phone>
    <email>johnlcs@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Show Chwan Memorial Hospital</name>
      <address>
        <city>Changhua City</city>
        <state>Changhua</state>
        <zip>500</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chien-Sheng Lo, MD</last_name>
      <phone>+886-975611289</phone>
      <email>johnlcs@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2017</study_first_submitted>
  <study_first_submitted_qc>June 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 5, 2017</study_first_posted>
  <last_update_submitted>June 2, 2017</last_update_submitted>
  <last_update_submitted_qc>June 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Show Chwan Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Pei-Yuan Lee, MD</investigator_full_name>
    <investigator_title>Superintendent</investigator_title>
  </responsible_party>
  <keyword>Platelet-Rich Plasma</keyword>
  <keyword>Meniscus</keyword>
  <keyword>Knee Injuries</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Knee Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

